AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 156 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $423,329 | +4.8% | 66,666 | 0.0% | 0.32% | -2.1% |
| Q1 2024 | $403,996 | -0.2% | 66,666 | 0.0% | 0.33% | -7.1% |
| Q4 2023 | $404,663 | +43.8% | 66,666 | 0.0% | 0.35% | +28.7% |
| Q3 2023 | $281,331 | +3.5% | 66,666 | -24.0% | 0.28% | +9.1% |
| Q2 2023 | $271,765 | +123.0% | 87,666 | 0.0% | 0.25% | +123.0% |
| Q1 2023 | $121,856 | -30.2% | 87,666 | 0.0% | 0.11% | -34.3% |
| Q4 2022 | $174,455 | -1.4% | 87,666 | 0.0% | 0.17% | -11.8% |
| Q3 2022 | $177,000 | -36.6% | 87,666 | 0.0% | 0.20% | -31.8% |
| Q2 2022 | $279,000 | -23.8% | 87,666 | 0.0% | 0.29% | -8.3% |
| Q1 2022 | $366,000 | -12.9% | 87,666 | 0.0% | 0.31% | -12.4% |
| Q4 2021 | $420,000 | -10.3% | 87,666 | 0.0% | 0.36% | -16.0% |
| Q3 2021 | $468,000 | +4.2% | 87,666 | 0.0% | 0.42% | +3.9% |
| Q2 2021 | $449,000 | -23.9% | 87,666 | 0.0% | 0.41% | -27.9% |
| Q1 2021 | $590,000 | +47.1% | 87,666 | 0.0% | 0.57% | +41.1% |
| Q4 2020 | $401,000 | – | 87,666 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 4,655,403 | $29,561,809 | 9.98% |
| TPG GP A, LLC | 12,328,767 | $78,287,670 | 1.80% |
| Rubric Capital Management LP | 10,721,778 | $68,083,290 | 1.78% |
| TUCKER ASSET MANAGEMENT LLC | 1,111,064 | $7,055,256 | 1.54% |
| BlackBarn Capital Partners LP | 2,000,000 | $12,700,000 | 1.13% |
| Nantahala Capital Management | 2,669,943 | $16,954,138 | 1.00% |
| SANDERS MORRIS HARRIS LLC | 567,196 | $3,601,695 | 0.59% |
| Jackson Creek Investment Advisors LLC | 161,760 | $1,027 | 0.38% |
| HENNESSY ADVISORS INC | 1,388,600 | $8,817,610 | 0.33% |
| Signature Wealth Management Partners, LLC | 66,666 | $423,329 | 0.32% |